The new office is in, what is called, the Regenerative Medicine Hub (RegenMed Hub™), where PHI will develop its non-invasive technology for cell quality control in the field of regenerative medicine. With this step, PHI will have access to Wake Forest Institute facilities and expertise to test and develop its non-invasive technology and to learn first-hand more about the present advances and in the field. To launch as soon as possible, PHI’s Chief Scientific Officer, Kersti Alm, will kick-start the office now mid-November.



Phase Holographic

Senast

1,18

1 dag %

0,86%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån